CIK 0001818382
- Non-accelerated filer
- Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851763759
- Phone
- +1 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- 4 Open-market buy Director bought 1,797 shares at $4.44 ($7,979)
- 4 Open-market sale President, CEO and Director sold 1,500,000 shares at an average $4.40 ($6,606,799)
- 4 Open-market sale Director sold 1,500,000 shares at an average $4.40 ($6,606,799)
- 4 Exercise or conversion Director acquired 1,200 shares (option exercise)
- 4 Open-market sale Director sold 5,182 shares at an average $5.40 ($28,004)
- 4 Open-market sale Director sold 446,378 shares at an average $5.30 ($2,364,521)
- 4 Open-market sale President, CEO and Director sold 446,378 shares at an average $5.30 ($2,364,521)
- 4 Open-market buy President, CEO and Director bought 1,222 shares at $6.55 ($7,998)
- 4 Open-market buy Director bought 1,222 shares at $6.55 ($7,998)
- 4 Open-market sale Director sold 881,878 shares at an average $6.49 ($5,724,139)
- 4 Open-market sale President, CEO and Director sold 881,878 shares at an average $6.49 ($5,724,139)
- 4 Open-market sale CFO and Chief Corp. Deve. Off. sold 39,389 shares at $6.68 ($263,119)
- 4 Open-market buy Director bought 3,100 shares at $6.29 ($19,494)
- 4 Exercise or conversion Director acquired 39,389 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 12 · 235 filings